Evidence map›Paper›PMID 33776158›Full record

ArticleProgress in polymer science2021

Recent Advances in 3D Printing with Protein-Based Inks.

Xuan Mu, Francesca Agostinacchio, Ning Xiang, Ying Pei, Yousef Khan, Chengchen Guo, Peggy Cebe, Antonella Motta, David L Kaplan

Open access · greenAbstract read
In one paragraph

Article in Progress in polymer science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
8.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 128 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Silk fibroin-based inks forBioactive materials · 2024
    Article
  6. Article
  7. Advanced Formulation Approaches for Proteins.Handbook of experimental pharmacology · 2024
    Review
  8. Review
  9. Review
  10. 3D Bioprinting for Vascularization.Bioengineering (Basel, Switzerland) · 2023
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Xuan MuDepartment of Biomedical Engineering, Tufts University, Medford, MA 02155, USA.
Francesca AgostinacchioDepartment of Biomedical Engineering, Tufts University, Medford, MA 02155, USA.
Ning XiangDepartment of Biomedical Engineering, Tufts University, Medford, MA 02155, USA.
Ying PeiDepartment of Biomedical Engineering, Tufts University, Medford, MA 02155, USA.
Yousef KhanDepartment of Biomedical Engineering, Tufts University, Medford, MA 02155, USA.
Chengchen GuoDepartment of Biomedical Engineering, Tufts University, Medford, MA 02155, USA.
Peggy CebeDepartment of Physics and Astronomy, Tufts University, Medford, MA 02155, USA.
Antonella MottaDepartment of Industrial Engineering, University of Trento, via Sommarive 9, Trento 38123, Italy.
David L KaplanDepartment of Biomedical Engineering, Tufts University, Medford, MA 02155, USA.
Tufts University · USUniversity of Trento · ITZhengzhou University · CN

Funding

Translational Bioreactors - Engineering Complex TissuesP41EB002520 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2004 to 2018
$16.7M
Tissue Engineering Resource Center: TTDP41EB027062 · NIBIB · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gordana Vunjak-Novakovic · 2019 to 2026
$12.6M
Models to Predict Protein Biomaterial PerformanceU01EB014976 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI BUEHLER, MARKUS J., KAPLAN, DAVID L. · 2012 to 2020
$5.2M
Functional three dimensional brain-like tissues to study mechanisms of traumatic brain injuryR01NS092847 · NINDS · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2015 to 2019
$1.8M
Injectable Gels for Tissue AugmentationR01EB021264 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI HOUSE, MICHAEL DOUGLAS, KAPLAN, DAVID L. · 2016 to 2019
$1.4M
NIBIB NIH HHS P41 EB002520NIBIB NIH HHS P41 EB027062NIBIB NIH HHS R01 EB021264NIBIB NIH HHS U01 EB014976NINDS NIH HHS R01 NS092847
6 · The paper itself

Abstract

Three-dimensional (3D) printing is a transformative manufacturing strategy, allowing rapid prototyping, customization, and flexible manipulation of structure-property relationships. Proteins are particularly appealing to formulate inks for 3D printing as they serve as essential structural components of living systems, provide a support presence in and around cells and for tissue functions, and also provide the basis for many essential ex vivo secreted structures in nature. Protein-based inks are beneficial in vivo due to their mechanics, chemical and physical match to the specific tissue, and full degradability, while also to promoting implant-host integration and serving as an interface between technology and biology. Exploiting the biological, chemical, and physical features of protein-based inks can provide key opportunities to meet the needs of tissue engineering and regenerative medicine. Despite these benefits, protein-based inks impose nontrivial challenges to 3D printing such as concentration and rheological features and reconstitution of the structural hierarchy observed in nature that is a source of the robust mechanics and functions of these materials. This review introduces photo-crosslinking mechanisms and rheological principles that underpins a variety of 3D printing techniques. The review also highlights recent advances in the design, development, and biomedical utility of monolithic and composite inks from a range of proteins, including collagen, silk, fibrinogen, and others. One particular focus throughout the review is to introduce unique material characteristics of proteins, including amino acid sequences, molecular assembly, and secondary conformations, which are useful for designing printing inks and for controlling the printed structures. Future perspectives of 3D printing with protein-based inks are also provided to support the promising spectrum of biomedical research accessible to these materials.

Indexed as

CollagenDirected assemblyFibrinogenPhotopolymerizationRheologySilkSimulation

Identifiers

PMID33776158
PMCPMC7996313
OpenAlexW3130792648

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.